Gyl Financial Synergies, LLC Becton Dickinson & CO Transaction History

Gyl Financial Synergies, LLC

$1.31 Billion
Q3 2024

A detailed history of Gyl Financial Synergies, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Gyl Financial Synergies, LLC holds 846 shares of BDX stock, worth $190,730. This represents 0.02% of its overall portfolio holdings.

Number of Shares

846

Previous 916 7.64%

Holding current value

$190,730

Previous $214,000 5.14%

% of portfolio

0.02%

Previous 0.02%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$221.47 - $242.41 $15,502 - $16,968	-70 Reduced 7.64%	846 $203,000
Q2 2024 Jul 23, 2024	SELL	$225.07 - $246.17 $1,125 - $1,230	-5 Reduced 0.54%	916 $214,000
Q1 2024 May 14, 2024	BUY	$233.45 - $247.73 $1,167 - $1,238	5 Added 0.55%	921 $227,000
Q4 2023 Feb 09, 2024	BUY	$232.24 - $267.23 $18,579 - $21,378	80 Added 9.57%	916 $223,000
Q3 2023 Nov 06, 2023	SELL	$254.9 - $283.59 $1,274 - $1,417	-5 Reduced 0.59%	836 $216,000
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $25,269 - $28,123	-106 Reduced 11.19%	841 $222,000
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $18,147 - $20,488	79 Added 9.1%	947 $234,000
Q4 2022 Feb 06, 2023	BUY	$218.29 - $256.91 $189,475 - $222,997	868 New	868 $220,000
Q2 2022 Aug 01, 2022	SELL	$234.74 - $275.42 $10,563 - $12,393	-45 Reduced 4.98%	859 $212,000
Q1 2022 May 05, 2022	SELL	$243.64 - $270.48 $150,325 - $166,886	-617 Reduced 40.57%	904 $240,000
Q1 2019 May 14, 2019	BUY	$206.05 - $248.17 $313,402 - $377,466	1,521 New	1,521 $380,000

Others Institutions Holding BDX

# of Institutions

1,737

Shares Held

250M

Call Options Held

690K

Put Options Held

787K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $64.3B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gyl Financial Synergies, LLC with notifications on news.

Account

Gyl Financial Synergies, LLC Becton Dickinson & CO Transaction History